Objective: To identify patients whose tumors express programmed death ligand 1 (PD-L1) for potential treatment eligibility with nivolumab or nivolumab and hyalu
Objective: To evaluate urinary concentrations of microbially derived metabolites in children with autism spectrum disorder (ASD) compared to typically developin
Children with autism spectrum disorder (ASD) exhibited higher urinary concentrations of microbially derived metabolites compared to typically developing controls.
The study achieved 90% sensitivity and 100% specificity in classifying children with ASD based on elevated metabolite levels.
Researchers identified over 600 metabolites differing between groups, with 23 of 24 selected metabolites significantly elevated in children with ASD.
The MDM System developed in the study assigned scores based on elevated metabolites, with children with ASD averaging a score of 3.3.
The study was a pilot and highlighted the need for replication in an independent cohort due to its limitations and exclusions.
Objective: To investigate the association between glucagon-like peptide-1 receptor agonists (GLP-1s) and the risk of anterior ischemic optic neuropathy compared
Objective: To evaluate the impact of real-time continuous glucose monitoring (CGM) on glycemic control in patients with insulin-treated type 2 diabetes receivin
Objective: To evaluate the intervals between computed tomography (CT) and computed tomography angiography (CTA) in patients with large-vessel occlusion stroke r
Objective: To identify and rank the most pressing concerns for laboratory leaders based on the 2026 Pain Points Survey conducted by the Panel of National Pathol
Objective: To investigate the influence of patient demographic information on diagnostic decision-making among medical students and residents. Approach: Study D
Objective: To demonstrate the functional impact of cataracts through a football-themed event. Approach: Event Description: Teams from SpaMedica and Freedom Visi
Objective: To announce the launch of the UNITY Cataract System (CS) in Canada during the COS Annual Meeting and Exhibition and highlight its features. Approach:
Objective: To explore advancements in presbyopia management through personalized progressive addition lenses (PALs) that cater to individual visual needs. Appro
Objective: To detail the collaboration between VIVEbiotech and Zelluna focused on GMP lentiviral vector manufacturing for TCR-NK cell therapy. Approach: Collabo
Objective: To develop and validate a predictive model for assessing the risk of anastomotic leakage (AL) in esophageal cancer patients undergoing esophagectomy.
Objective: To develop a novel anti-inflammatory CAR-Microglia (CAR-Mic) targeting amyloid-β (Aβ) for enhanced clearance and reduced neuroinflammation in Alzheim
Alzheimer's disease is marked by amyloid-β plaque accumulation and chronic neuroinflammation, leading to neuronal loss and cognitive decline.
Monoclonal antibodies targeting amyloid-β have shown limited efficacy due to insufficient clearance and treatment-associated neuroinflammation.
A novel anti-inflammatory CAR-Microglia was developed, utilizing TAM receptors to enhance Aβ clearance while reducing proinflammatory cytokine release.
AXL-CAR-iMGLs demonstrated improved Aβ clearance in an AD mouse model without severe adverse effects, indicating potential for cell therapy.
The study establishes TAM receptor-based CAR-iMGLs as a promising approach for treating Alzheimer's disease and other neurodegenerative disorders.
Objective: To explore the mechanisms of programmed cell death (PCD) induced by traditional plant medicine (TPM) in the treatment of prostate cancer (PCa). Appro
Objective: To identify independent predictors of stroke-associated pneumonia (SAP) in patients with acute isolated pontine infarction (AIPI) and to investigate
Objective: To explore the underutilisation of rehabilitation services for children with cancer in Gaza, particularly in the context of ongoing conflict. Approac
Objective: To compare the effectiveness of initiating buprenorphine-naloxone versus extended-release naltrexone specifically after opioid withdrawal management.
Objective: To determine whether early sequential application of Enhanced External Counterpulsation (EECP) followed by Electric Tilt Table (ETT) training improve